Cargando…

Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells

To compare the drug-induced efficacies between omidenepag (OMD), an EP2 agonist, and prostaglandin F2α (PGF2α) on glaucomatous trabecular meshwork (TM) cells, two- and three-dimensional (2D and 3D) cultures of TGF-β2-modulated human trabecular meshwork (HTM) cells were used. The following analyses w...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Soma, Furuhashi, Masato, Tsugeno, Yuri, Umetsu, Araya, Ida, Yosuke, Hikage, Fumihito, Ohguro, Hiroshi, Watanabe, Megumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954773/
https://www.ncbi.nlm.nih.gov/pubmed/35329980
http://dx.doi.org/10.3390/jcm11061652
_version_ 1784676176161144832
author Suzuki, Soma
Furuhashi, Masato
Tsugeno, Yuri
Umetsu, Araya
Ida, Yosuke
Hikage, Fumihito
Ohguro, Hiroshi
Watanabe, Megumi
author_facet Suzuki, Soma
Furuhashi, Masato
Tsugeno, Yuri
Umetsu, Araya
Ida, Yosuke
Hikage, Fumihito
Ohguro, Hiroshi
Watanabe, Megumi
author_sort Suzuki, Soma
collection PubMed
description To compare the drug-induced efficacies between omidenepag (OMD), an EP2 agonist, and prostaglandin F2α (PGF2α) on glaucomatous trabecular meshwork (TM) cells, two- and three-dimensional (2D and 3D) cultures of TGF-β2-modulated human trabecular meshwork (HTM) cells were used. The following analyses were performed: (1) transendothelial electrical resistance (TEER) and FITC-dextran permeability measurements (2D), (2) the size and stiffness of the 3D spheroids, and (3) the expression (both 2D and 3D) by several extracellular matrix (ECM) molecules including collagen (COL) 1, 4 and 6, and fibronectin (FN), and α smooth muscle actin (αSMA), tight junction (TJ)-related molecules, claudin11 (Cldn11) and ZO1, the tissue inhibitor of metalloproteinase (TIMP) 1–4, matrix metalloproteinase (MMP) 2, 9 and 14, connective tissue growth factor (CTGF), and several endoplasmic reticulum (ER) stress-related factors. TGF-β2 significantly increased the TEER values and decreased FITC-dextran permeability, respectively, in the 2D HTM monolayers, and induced the formation of downsized and stiffer 3D HTM spheroids. TGF-β2-induced changes in TEER levels and FITC-dextran permeability were remarkably inhibited by PGF2α. PGF2α induced increases in the sizes and stiffness of the TGF-β2-treated 3D spheroids, but OMD enhanced only spheroid size. Upon exposure to TGF-β2, the expression of most of the molecules that were evaluated were significantly up-regulated, except some of ER stress-related factors were down-regulated. TJ-related molecules or ER stress-related factors were significantly up-regulated (2D) or down-regulated (3D), and down-regulated (2D) by PGF2α and OMD, while both drugs altered the expression of some of the other genes in the 3D spheroids in a different manner. The findings presented herein suggest that PGF2α and OMD differently modulate the permeability of the TGFβ2-modulated 2D monolayers and the physical properties of the 3D HTM spheroids.
format Online
Article
Text
id pubmed-8954773
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89547732022-03-26 Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells Suzuki, Soma Furuhashi, Masato Tsugeno, Yuri Umetsu, Araya Ida, Yosuke Hikage, Fumihito Ohguro, Hiroshi Watanabe, Megumi J Clin Med Article To compare the drug-induced efficacies between omidenepag (OMD), an EP2 agonist, and prostaglandin F2α (PGF2α) on glaucomatous trabecular meshwork (TM) cells, two- and three-dimensional (2D and 3D) cultures of TGF-β2-modulated human trabecular meshwork (HTM) cells were used. The following analyses were performed: (1) transendothelial electrical resistance (TEER) and FITC-dextran permeability measurements (2D), (2) the size and stiffness of the 3D spheroids, and (3) the expression (both 2D and 3D) by several extracellular matrix (ECM) molecules including collagen (COL) 1, 4 and 6, and fibronectin (FN), and α smooth muscle actin (αSMA), tight junction (TJ)-related molecules, claudin11 (Cldn11) and ZO1, the tissue inhibitor of metalloproteinase (TIMP) 1–4, matrix metalloproteinase (MMP) 2, 9 and 14, connective tissue growth factor (CTGF), and several endoplasmic reticulum (ER) stress-related factors. TGF-β2 significantly increased the TEER values and decreased FITC-dextran permeability, respectively, in the 2D HTM monolayers, and induced the formation of downsized and stiffer 3D HTM spheroids. TGF-β2-induced changes in TEER levels and FITC-dextran permeability were remarkably inhibited by PGF2α. PGF2α induced increases in the sizes and stiffness of the TGF-β2-treated 3D spheroids, but OMD enhanced only spheroid size. Upon exposure to TGF-β2, the expression of most of the molecules that were evaluated were significantly up-regulated, except some of ER stress-related factors were down-regulated. TJ-related molecules or ER stress-related factors were significantly up-regulated (2D) or down-regulated (3D), and down-regulated (2D) by PGF2α and OMD, while both drugs altered the expression of some of the other genes in the 3D spheroids in a different manner. The findings presented herein suggest that PGF2α and OMD differently modulate the permeability of the TGFβ2-modulated 2D monolayers and the physical properties of the 3D HTM spheroids. MDPI 2022-03-16 /pmc/articles/PMC8954773/ /pubmed/35329980 http://dx.doi.org/10.3390/jcm11061652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Suzuki, Soma
Furuhashi, Masato
Tsugeno, Yuri
Umetsu, Araya
Ida, Yosuke
Hikage, Fumihito
Ohguro, Hiroshi
Watanabe, Megumi
Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
title Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
title_full Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
title_fullStr Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
title_full_unstemmed Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
title_short Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells
title_sort comparison of the drug-induced efficacies between omidenepag isopropyl, an ep2 agonist and pgf2α toward tgf-β2-modulated human trabecular meshwork (htm) cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954773/
https://www.ncbi.nlm.nih.gov/pubmed/35329980
http://dx.doi.org/10.3390/jcm11061652
work_keys_str_mv AT suzukisoma comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT furuhashimasato comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT tsugenoyuri comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT umetsuaraya comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT idayosuke comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT hikagefumihito comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT ohgurohiroshi comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells
AT watanabemegumi comparisonofthedruginducedefficaciesbetweenomidenepagisopropylanep2agonistandpgf2atowardtgfb2modulatedhumantrabecularmeshworkhtmcells